High-Dose Capsaicin Patch Placement
A single 8% capsaicin patch targets damaged peripheral nerve endings.
- 8%: Capsaicin concentration (640× a standard OTC cream)
- 30–90: Application time (minutes, clinic-supervised)
- 2009: FDA approval (Qutenza, for PHN & DPN)
- Topical: Pretreatment (lidocaine numbs the area first)
Why such a high dose
Low-dose creams barely activate TRPV1 receptors at all.
A single high-dose patch replaces months of daily low-dose cream use.
Targeting damaged nerves
Peripheral neuropathy leaves nociceptor terminals hypersensitive and exposed.
TRPV1 Channel Opening & Initial Burning
Capsaicin locks onto TRPV1, a heat- and pain-sensing ion channel.
- 1997: TRPV1 discovery (cloned by Caterina et al.)
- Ligand-gated: Channel type (nonselective cation channel)
- <60 sec: Burning onset (after capsaicin contact)
- 8–10: Peak burning score (on a 0–10 pain scale)
A lock-and-key ion channel
Capsaicin binds the TRPV1 vanilloid pocket, forcing the pore open.
TRPV1 also senses heat above 43°C — capsaicin just hijacks the same switch.
The transient burning phase
Sodium and calcium rush in, firing nociceptors intensely but briefly.
Sustained Calcium Influx Into Nerve Terminals
Prolonged TRPV1 opening lets far more calcium enter than the terminal can handle.
- >100×: Ca²⁺ concentration rise (above resting cytosolic level)
- High: Mitochondrial stress (calcium uptake overloads organelles)
- 30–90 min: Exposure needed (to drive lasting overload)
- Severe: Cytoskeletal impact (microtubule transport disrupted)
Calcium as the overload signal
Sustained influx overwhelms buffering, stressing mitochondria and the cytoskeleton.
This calcium overload — not tissue damage — is what drives desensitization.
Distinguishing overload from injury
The nerve fiber itself survives; only its terminal function shuts down.
Reversible Nerve Terminal Defunctionalization
Overloaded terminals retract and stop signaling pain, without permanent nerve death.
- 30–85%: Terminal density drop (depending on exposure time)
- Reversible: Process type (axon body remains intact)
- Days: Onset after patch (terminals thin progressively)
- Ca²⁺-driven: Mechanism (not thermal or chemical burn)
Terminals retract, not die
Nerve fibers pull back from the epidermis and lose signaling ability.
Defunctionalization silences pain signals while sparing the underlying neuron.
Dose-dependent retraction depth
Longer patch exposure drives deeper, longer-lasting terminal thinning.
Weeks of Sustained Analgesia & Regrowth
Reduced nociceptor terminal density keeps neuropathic pain signals quiet for months.
- up to 12: Relief duration (weeks per single treatment)
- Every 3 mo: Repeat treatment (as terminals regrow)
- Gradual: Regrowth pattern (terminals reinnervate epidermis slowly)
- Minimal: Systemic side effects (action stays localized to skin)
A localized, lasting effect
Pain relief tracks how sparse the nociceptor terminals remain.
Terminals slowly reinnervate the skin, so relief eventually fades and can be repeated.
Regrowth resets the clock
As density recovers toward baseline, sensitivity and pain gradually return.